Targeted disruption of the mouse Lipoma Preferred Partner gene

被引：24
|
作者：
Vervenne, Hilke B. V. K. [1 ]
Crombez, Koen R. M. O. [1 ]
Delvaux, Els L. [1 ]
Janssens, Veerle [2 ]
de Ven, Wim J. M. Van [1 ]
Petit, Marleen M. R. [1 ]
机构：
[1] Katholieke Univ Leuven, Dept Human Genet, Mol Oncol Lab, Louvain, Belgium
[2] Katholieke Univ Leuven, Dept Mol Cell Biol, Prot Phosphorylat & Prote Lab, Louvain, Belgium
来源：
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS | 2009年 / 379卷 / 02期
关键词：
Zyxin; LPP; Lipoma Preferred Partner; TRIP6; ZRP-1; Knockout; Migration; Fertility; Female lethality; Aberrant pregnancy; SMOOTH-MUSCLE EXPRESSION; EXTENSION MOVEMENTS; FOCAL ADHESION; PROTEIN LPP; FUSION; ZYXIN; PEA3; MIGRATION; INTERACTS; CAPACITY;
D O I：
10.1016/j.bbrc.2008.12.074
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
LPP (Lipoma Preferred Partner) is a zyxin-related cell adhesion protein that is involved in the regulation of cell migration. We generated mice with a targeted disruption of the Lpp gene and analysed the importance of Lpp for embryonic development and adult functions. Aberrant Mendelian inheritance in heterozygous crosses suggested partial embryonic lethality of Lpp(-/-) females. Fertility of Lpp(-/-) males was proven to be normal, however, females from Lpp(-/-) x Lpp(-/-) crosses produced a strongly reduced number of offspring, probably due to a combination of female embryonic lethality and aberrant pregnancies. Apart from these developmental and reproductive abnormalities, Lpp(-/-) mice that were born reached adulthood without displaying any additional macroscopic defects. Oil the other hand, Lpp(-/-) mouse embryonic fibroblasts exhibited reduced migration capacity, reduced viability, and reduced expression of some Lpp interaction partners. Finally, we discovered a short nuclear form of Lpp, expressed mainly in testis via an alternative promoter. (c) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码：368 / 373
页数：6
相关论文
共 50 条
  • [41] Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality
    Takeda, K
    Noguchi, K
    Shi, W
    Tanaka, T
    Matsumoto, M
    Yoshida, N
    Kishimoto, T
    Akira, S
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (08) : 3801 - 3804
  • [42] Targeted disruption of the mouse phospholipase C β3 gene results in early embryonic lethality
    Wang, S
    Gebre-Medhin, S
    Betsholtz, C
    Stålberg, P
    Zhou, YH
    Larsson, C
    Weber, G
    Feinstein, R
    Öberg, K
    Gobl, A
    Skogseid, B
    FEBS LETTERS, 1998, 441 (02) : 261 - 265
  • [43] Generation of a mouse model for arginase II deficiency by targeted disruption of the arginase II gene
    Shi, O
    Morris, SM
    Zoghbi, H
    Porter, CW
    O'Brien, WE
    MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (03) : 811 - 813
  • [44] Targeted disruption of the IMPDH: Type II gene: Effect on mouse development and lymphocyte activation
    Gu, JJ
    Stegmann, S
    Mitchell, BS
    INOSINE MONOPHOSPHATE DEHYDROGENASE: A MAJOR THERAPEUTIC TARGET, 2003, 839 : 91 - 109
  • [45] TARGETED DISRUPTION OF THE MOUSE FACTOR-VIII GENE PRODUCES A MODEL OF HEMOPHILIA-A
    BI, L
    LAWLER, AM
    ANTONARAKIS, SE
    HIGH, KA
    GEARHART, JD
    KAZAZIAN, HH
    NATURE GENETICS, 1995, 10 (01) : 119 - 121
  • [46] Targeted disruption of the Cln3 gene provides a mouse model for Batten disease
    Mitchison, HM
    Bernard, DJ
    Greene, NDE
    Cooper, JD
    Junaid, MA
    Pullarkat, RK
    de Vos, N
    Breuning, MH
    Owens, JW
    Mobley, WC
    Gardiner, RM
    Lake, BD
    Taschner, PEM
    Nussbaum, RL
    NEUROBIOLOGY OF DISEASE, 1999, 6 (05) : 321 - 334
  • [47] Preferred partner
    Textile Month, 2002, (APR):
  • [48] The preferred partner
    Morgan, P
    CHEMISTRY & INDUSTRY, 2004, (10) : 23 - 24
  • [49] Targeted gene disruption: Applications in neurobiology
    vanderNeut, R
    JOURNAL OF NEUROSCIENCE METHODS, 1997, 71 (01) : 19 - 27
  • [50] Targeted disruption of the murine galanin gene
    Wynick, D
    Small, CJ
    Bloom, SR
    Pachnis, V
    GALANIN: BASIC RESEARCH DISCOVERIES AND THERAPEUTIC IMPLICATIONS, 1998, 863 : 22 - 47
12345